Skip to content

Study on the effects and mechanisms of "Metabolic stress-ferroptosis" to delay the progression of diabetic nephropathy by Heat-clearing and Mass-eliminating Chinese Herbs

Study on the effects and mechanisms of "Metabolic stress-ferroptosis" to delay the progression of diabetic nephropathy by Heat-clearing and Mass-eliminating Chinese Herbs

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074286
Enrollment
Unknown
Registered
2023-08-03
Start date
2023-08-03
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy

Interventions

The control group:Diabetes diet, control of blood sugar, blood lipids, blood pressure and other treatments were given according to the Chinese Guidelines for the Prevention and Treatment of diabetic n
Experimental group:Patients in the control group on the basis of the treatment to check dissipate disease.Chinese medicine made from fujian province people's hospital pharmacy department purchasing an

Sponsors

People's hospital affiliated to fujian university of traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) in line with the western medicine diagnosis and staging criteria; G1A2 stage of diabetic nephropathy(2) in accordance with the traditional Chinese medicine qi Yin deficiency of damp and hot clip stasis syndrome diagnostic standard;(3) the age of 25 to 75 years of age, gender not limited;(4) the basic step-down, blood pressure 140/90 mmHg or less person (greater than 60 elderly systolic blood pressure, 150 mmHg or less), via based hypoglycemic, blood sugar control DaBiaoZhe (glycated hemoglobin (HbA1c) 7.5% or less).(5) in the first 3 months did not take any drug clinical subjects;(6) volunteered for this study and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) recent (4 weeks) with severe infection, moderately severe anemia, electrical solution quality, and the disorders, diabetes, acute complications, etc.;(2) into the group of the first 3 months had serious heart, brain, liver and hematopoietic system such as severe disease (cerebral infarction, cerebral hemorrhage, transient ischemic attack, myocardial infarction, unstable angina, heart failure, transaminases associated to the upper limit of the normal range) for more than 2 times, and used corticosteroids or immunosuppressants;(3) oliguria or anuria, severe edema, massive pleural effusion peritoneal effusion;(4) have a mental illness, kidney transplantation;(5) pregnancy or ready to pregnancy, lactation women;(6) known to the drug allergy, hepatitis b tests suggest e antigen positive people.

Design outcomes

Primary

MeasureTime frame
Urinary albumin/creatinine ratio;

Secondary

MeasureTime frame
Serum creatinine;Urea nitrogen;Cystain C;N-acetyl-ß-D-glucosaminidase;Microglobulin urine ß2;Glycated hemoglobin;Fasting plasma glucose;Total cholesterol;Triglyceride;Low density lipoprotein cholesterol;High-density lipoprotein cholesterol;Serum Ferritin;Lactate dehydrogenase;Propylene glycol;Glutathione peroxidase 4;Nuclear factor of red blood cells factor related factor 2;Traditional Chinese Medicine Syndrome Curative Effect;

Countries

China

Contacts

Public ContactBinhua Ye

People's hospital affiliated to fujian university of traditional Chinese medicine

1277214181@qq.com+86 132 7591 1822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026